Trial Profile
A retrospective observational study to determine clinical effectiveness of Sarilumab treatment in patients with Graves' orbitopathy in routine clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jun 2022
Price :
$35
*
At a glance
- Drugs Sarilumab (Primary) ; Interleukin 6 inhibitors; Tocilizumab
- Indications Graves ophthalmopathy
- Focus Therapeutic Use
- 24 Jun 2022 New trial record
- 04 Jun 2022 Results presented at the 23rd Annual Congress of the European League Against Rheumatism